Health and Healthcare
618 Articles
AuthorDendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a takeover target. As…
By now, most investors know that the large hedge funds are run by billionaires rather than millionaires. What many investors…
Indian drug maker Sun Pharmaceutical Industries Ltd. has received approval from the US Food and Drug Administration to sell its…
All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to…
Drug maker Eli Lilly & Co. reported fourth quarter and full year earnings this morning, and although revenues were higher…
Profits at Eli Lilly & Co. (NYSE: LLY) in 2012 will be sharply lower than analysts had been expecting. The…
Greece will announce its new government today. (Reuters) Inflation in China drops in October. (Reuters) Olympus investment losses may have…
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability.…
Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning. The…
Apple Inc (NASDAQ: AAPL) reported better than expected earnings and its shares soared (Reuters) Yahoo!’s (NASDAQ: YHOO) revenue fell (Reuters)…
The number of stocks that made substantial gains for the week was limited. The great exception to that rule was…
Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key…
We may have just witnessed an oversold bounce in the stock market, or we may be in for more days…
NYSE (NYSE: NYX) was thrashed as Nasdaq (NASDAQ: NDAQ) and ICE pulled their buyout offer due to regulatory concerns. Hewlett-Packard…
Our top personal finance-related articles today. Your wallet will thank you later.